Alternatives to Abeona Therapeutics
Abeona Therapeutics is a Biotech tool: a commercial-stage biopharmaceutical company developing cell and gene therapies for rare diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Abeona Therapeutics
- Website
Travere Therapeutics51BiotechnologySan Diego, USA$63.0MA biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
- Website
Integra Therapeutics54BiotechBarcelona, Spain$134.8MBiotech company developing next-generation gene writing tools for advanced therapies.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website
Gene Bio Medical36BiotechTel Aviv, Israel$10.0MDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
Harmony Biosciences Holdings57BiotechPlymouth Meeting, United States$400.5MBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
- Website
Amicus Therapeutics57BiotechPhiladelphia, United States$200.0MBiotechnology company focused on developing treatments for rare metabolic diseases.
- Website
Mustang Bio41BiotechWorcester, United StatesClinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.
- Website
Regenxbio55BiotechRockville, United States$180.0MClinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
- Website
Tenaya Therapeutics55BiotechSouth San Francisco, United States$158.5MBiotechnology company developing gene therapies and regenerative medicine for heart disease.
- Website
Adaptam Therapeutics53BiotechCambridge, United States$4.7MDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.
- Website
Rezolute52BiotechRedwood City, United States$220.0MBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
- Website
Bluebird Bio51BiotechSomerville, United States$1.0BGene therapy company developing transformative treatments for severe genetic diseases.
- Website RIRidge Bio50BiotechSan Francisco, United States$135.0M
Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.
- Website
Lift Biosciences46BiotechCambridge, United Kingdom$18.0MDeveloping advanced cell culture media and bioprocessing solutions for cell and gene therapy.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
Lutris Pharma39BiotechSan Diego, United States$170.0MLutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.
Showing the 20 closest matches. See the rest on the Abeona Therapeutics profile.
Compare Abeona Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.